Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Why Medical Sourcing Matters: Purity, Counterfeits, and the WADA Ban One of the most overlooked parts of the AOD 9604 conversation is where the product actually comes from
The available evidence consists primarily of animal studies and limited early-phase human trials, with no published phase III clinical trial data demonstrating efficacy in inflammatory bowel disease (IBD).[1][2] The literature describes BPC-157 as a stable gastric pentadecapeptide that was tested in phase II clinical trials for inflammatory bowel disease (referenced as PL 14736), with reports indicating it was "safe" and had "no side effects." However, a 2025 review emphasizes that BPC-157 "has not been approved for use in standard medicine by the FDA and other global regulatory authorities due to the absence of sufficient and comprehensive clinical studies confirming its health benefits in humans."[1][3][2] The preclinical evidence is extensive but limited to animal models
BPC-157 has a large following based on animal research and user reports
However, theres a lack of customer reviews on their site and customer service needs improvement
US$ 23.30
US$ 25.14
US$ 22.10
US$ 20.05
US$ 26.34
US$ 20.56